Can bupropion (Wellbutrin) raise blood pressure, particularly at doses of 300 mg per day or higher?

Yes, bupropion can raise blood pressure and requires monitoring

Bupropion treatment can result in elevated blood pressure and hypertension, requiring blood pressure assessment before initiation and periodic monitoring during treatment. 1

Mechanism and Clinical Evidence

Bupropion is a norepinephrine and dopamine reuptake inhibitor, and its effects on the adrenergic system can lead to blood pressure elevations. The FDA drug label explicitly warns that treatment with bupropion can result in elevated blood pressure and hypertension 1.

Magnitude of Blood Pressure Changes

The blood pressure increases with bupropion are generally modest but clinically significant:

• In seasonal affective disorder trials, bupropion caused a mean increase in systolic blood pressure of 1.3 mmHg (statistically significant, p=0.013) and 0.8 mmHg in diastolic blood pressure (not statistically significant) 1
• In a controlled study of patients with mild untreated hypertension, bupropion SR 300 mg/day showed less reduction in systolic blood pressure compared to placebo (-4.20 vs -6.53 mmHg), though the clinical significance was limited 2
• When used as part of naltrexone-bupropion ER combination therapy, slight elevations in both blood pressure and heart rate have been observed 3

High-Risk Scenarios

Bupropion poses greater hypertensive risk in specific situations:

• Combination therapy: When bupropion SR was combined with nicotine transdermal system (NTS) for smoking cessation, 6.1% of patients developed treatment-emergent hypertension compared to 2.5% with bupropion alone 1
• Pre-existing hypertension: In patients with stable congestive heart failure, bupropion was associated with exacerbation of pre-existing hypertension in 2 subjects, leading to treatment discontinuation 1
• Higher doses: At 300 mg per day (the typical therapeutic dose), blood pressure effects are present and require monitoring 1

Clinical Monitoring Requirements

Blood pressure must be assessed before starting bupropion and monitored periodically during treatment 1. This is particularly critical:

• During the first 12 weeks when using naltrexone-bupropion ER 4
• When combined with nicotine replacement therapy for smoking cessation 1
• In patients with pre-existing cardiovascular disease or hypertension 5

Contraindications and Precautions

Bupropion (as part of naltrexone-bupropion ER) is contraindicated in patients with uncontrolled hypertension 3. The 2025 AACE guidelines explicitly list uncontrolled hypertension as a contraindication for naltrexone-bupropion ER 3.

The risk of hypertension is increased when bupropion is used concomitantly with MAOIs or other drugs that increase dopaminergic or noradrenergic activity 1.

Comparative Safety Profile

Despite the blood pressure effects, bupropion's cardiovascular profile may still be favorable compared to some alternatives:

• In depressed patients with heart disease, bupropion caused a rise in supine blood pressure but had a low rate of orthostatic hypotension and no significant conduction complications 5
• Compared to tricyclic antidepressants like nortriptyline, bupropion appears to have a wider cardiovascular safety margin, particularly regarding orthostatic changes and cardiac conduction 6

Common Pitfalls to Avoid

1. Don't assume blood pressure effects are negligible - While modest on average, individual patients can experience clinically significant elevations
2. Don't overlook combination therapy risks - The hypertensive effect is amplified when combined with nicotine replacement
3. Don't skip baseline assessment - Always measure blood pressure before initiating therapy
4. Don't use in uncontrolled hypertension - This is an absolute contraindication for combination products containing bupropion